Pulmatrix's Series B - II Round

Pulmatrix raised a round of funding on August 15, 2011.

Pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. The platform, called iSPERSE (inhaled small particles easily…

Articles about Pulmatrix's Series B - II Round: